Novartis - Generics Unit's Unit Acquisition

Novartis - Generics Unit raised a round of funding on May 07, 2018. Investors include Aurobindo Pharma.

Novartis (NYSE: NVS) is a global healthcare company that provides solutions to address the evolving needs of patients worldwide. Focusing solely on healthcare, Novartis offers a diversified portfolio …

Articles about Novartis - Generics Unit's Unit Acquisition: